Delivery Order SPE2DR25D2002-SPE2DR26FBSL4
Award Date 12/8/25
Potential Completion Date 12/9/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,094.49 for IPOL vials (5mL) on July 15, 2025, with completion expected by July 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,870.10 on August 4, 2025, for the supply of IPOL Vial 5ML pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML pharmaceutical product, with a ceiling value of $1,544.12. This competitive award, issued on September 14, 2025, with an ultimate completion date of September 15, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,563.97 for IPOL Vial 5ML pharmaceutical products on October 29, 2025, with completion expected by October 30, 2025. This competitively awarded, non-set-aside contract is funded by the Defense Logistics Agency's Medical Supply Chain division and performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award utilizes firm fixed-price contract terms and represents a child delivery order under a...
- The Defense Logistics Agency awarded a delivery order valued at $1,150.61 to AmerisourceBergen Drug Corp for the supply of Ipol vial 5ML pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on December 4, 2025, with an ultimate completion date of December 5, 2025. The award carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,802.00, is for the delivery of IPOL VIAL 5ML medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,541.00 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IPOL VIAL 5ML medical products, with a completion date of December 14, 2021. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $1,652.21 to AmerisourceBergen Drug Corp for IPOL vial 5ML, a poliomyelitis vaccine product. The contract, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, is a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a competitive procurement action under an existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,180.20 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Ipol Vial 5ML, a polio vaccine product. This is a firm fixed price, non-competitive delivery order with a completion date of May 28, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under a larger vehicle—AmerisourceBergen's Indefinite Delivery...
- This is a $1,067.30 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4565297327 IPOL VIAL 5ML, with a completion date of August 1, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies, including the military. This contract is part of Amerisourcebergen's...